NO128798B - - Google Patents
Download PDFInfo
- Publication number
- NO128798B NO128798B NO00068/71A NO6871A NO128798B NO 128798 B NO128798 B NO 128798B NO 00068/71 A NO00068/71 A NO 00068/71A NO 6871 A NO6871 A NO 6871A NO 128798 B NO128798 B NO 128798B
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- water
- piperidine
- soluble
- ether
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 11
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 150000003840 hydrochlorides Chemical class 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 6
- QKSGIGXOKHZCQZ-UHFFFAOYSA-N 2-chloro-2-phenylacetic acid Chemical class OC(=O)C(Cl)C1=CC=CC=C1 QKSGIGXOKHZCQZ-UHFFFAOYSA-N 0.000 description 4
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002048 spasmolytic effect Effects 0.000 description 3
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960004126 codeine Drugs 0.000 description 2
- 150000001875 compounds Chemical group 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- XDXXBFXNXAGXIA-UHFFFAOYSA-N 1-butan-2-yloxyethanol Chemical compound CCC(C)OC(C)O XDXXBFXNXAGXIA-UHFFFAOYSA-N 0.000 description 1
- FGEAOSXMQZWHIQ-UHFFFAOYSA-N 2-chloro-2-phenylacetyl chloride Chemical compound ClC(=O)C(Cl)C1=CC=CC=C1 FGEAOSXMQZWHIQ-UHFFFAOYSA-N 0.000 description 1
- ROLMZTIHUMKEAI-UHFFFAOYSA-N 4,5-difluoro-2-hydroxybenzonitrile Chemical compound OC1=CC(F)=C(F)C=C1C#N ROLMZTIHUMKEAI-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- -1 aromatic carbon hydrogen Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000003170 musculotropic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N phenyl acetate Chemical class CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K7/00—Constructional details common to different types of electric apparatus
- H05K7/02—Arrangements of circuit components or wiring on supporting structure
- H05K7/12—Resilient or clamping means for holding component to structure
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01H—ELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
- H01H50/00—Details of electromagnetic relays
- H01H50/14—Terminal arrangements
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K7/00—Constructional details common to different types of electric apparatus
- H05K7/14—Mounting supporting structure in casing or on frame or rack
- H05K7/1417—Mounting supporting structure in casing or on frame or rack having securing means for mounting boards, plates or wiring boards
Landscapes
- Engineering & Computer Science (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Coupling Device And Connection With Printed Circuit (AREA)
- Multi-Conductor Connections (AREA)
- Combinations Of Printed Boards (AREA)
- Hydrogenated Pyridines (AREA)
Description
Fremgangsmåte for fremstilling av terapeutisk virksomme basiske estere. Process for the production of therapeutically active basic esters.
Det er kjent at blant fenylacetatene It is known that among the phenyl acetates
av (3-dietylamino-etyl med en supplemen-tær substituent på det kullstoffatom som of (3-diethylamino-ethyl) with an additional substituent on the carbon atom which
bærer fenylgruppen finnes forbindelser compounds bearing the phenyl group are found
med spasmolytisk virkning. with spasmolytic effect.
Det har nå vist seg at a-fenyl-a-piperidin-acetater av (3'-alkoksyetyl har spas-molytiske, lokalanestetiske og antitussive It has now been shown that α-phenyl-α-piperidine-acetates of (3'-Alkoxyethyl) have spasmolytic, local anesthetic and antitussive
egenskaper og at de på grunn av sin ikke-giftige karakter har stor betydning for properties and that, due to their non-toxic nature, they are of great importance to
terapeutisk bruk, særlig i form av vann-oppløselige salter. therapeutic use, particularly in the form of water-soluble salts.
Foreliggende oppfinnelse angår en The present invention relates to a
fremgangsmåte for fremstilling av disse method for producing these
basiske estere og denne fremgangsmåte be-står i at ct-fenyl-a-halogenacetater av P'-alkoksyetyl kondenseres med piperidin i basic esters and this method consists in ct-phenyl-α-haloacetates of β'- alkoxyethyl being condensed with piperidine in
nærvær av et fikseringsmiddel for den presence of a fixative for it
dannede halogenvannstoffsyre, fortrinsvis formed hydrohalic acid, preferably
i et vannfritt og inert organisk miljø. in an anhydrous and inert organic environment.
Spesielt kan det brukes et passende In particular, a suitable can be used
overskudd av piperidin som fikseringsmiddel for klorvannstoffsyre. Det organiske excess of piperidine as fixing agent for hydrochloric acid. The organic
vannfri og inerte miljø kan bestå av et water-free and inert environment can consist of a
aromatisk kullvannstoff, særlig av benzen. aromatic carbon hydrogen, especially of benzene.
a-fenyl-a-halogenacetater, spesielt a-fenyl a-kloracetater, av (5'-alkoksyetyl er α-Phenyl-α-haloacetates, especially α-phenyl α-chloroacetates, of (5'-Alkoxyethyl is
nye. De kan fremstilles ved hjelp av hvil-ken som helst kjent forestrings-prosess, new. They can be produced using any known esterification process,
særlig ved å omsette a-fenyl-a-halogen-eddiksyreklorider med |3-alkoksyetanoler. in particular by reacting α-phenyl-α-halogenoacetic acid chlorides with β-alkoxyethanols.
a-fenyl-a-piperidinacetater av |3'-alkoksyetyl som har den alminnelige formel α-Phenyl-α-piperidine acetates of |3'-Alkoxyethyl having the general formula
hvor R er en alkylgruppe, er i alminnelighet farveløse væsker som destillerer over i vakuum, er oppløselige i alkohol, eter og i andre vanlige organiske oppløsningsmid-ler, men uoppløselige i vann. Deres hydro-klorider, som f. eks. kan oppnås ved å opp-løse basene i vannfri eter og ved å lede en strøm av tørr klorvannstoffgass inn i eter-oppløsningen, er krystalliserte og hvite stoffer hvorav enkelte er meget hygrosko-piske. De er oppløselige i vann. Til gjen-gjeld er hydrobromidene ikke hygroskopis-ke og meget oppløselige i vann og etylal-kohol, således at de er mere bekvemme å bruke. where R is an alkyl group, are generally colorless liquids which distil in vacuo, are soluble in alcohol, ether and other common organic solvents, but insoluble in water. Their hydrochlorides, such as can be obtained by dissolving the bases in anhydrous ether and by passing a stream of dry hydrogen chloride gas into the ether solution, are crystallized and white substances, some of which are very hygroscopic. They are soluble in water. In return, the hydrobromides are not hygroscopic and very soluble in water and ethyl alcohol, so that they are more convenient to use.
Særlig viktige forbindelser i denne klasse er hydrokloridet og hydrobromidet av a-fenyl-a-piperidinacetat av |3'-n-butoksyetyl. De kan likestilles med papaverin hva angår deres muskulotrope spasmoly-tiske virkning, og de har en 5 ganger større lokalanestetisk virkning enn prokain på hornhinnen hos kaniner. De har dessuten en 2 til 3 ganger større antitussiv virkning enn kodein. Particularly important compounds in this class are the hydrochloride and hydrobromide of α-phenyl-α-piperidine acetate of |3'-n-butoxyethyl. They can be equated with papaverine in terms of their musculotropic spasmolytic effect, and they have a 5 times greater local anesthetic effect than procaine on the cornea of rabbits. They also have a 2 to 3 times greater antitussive effect than codeine.
Endelig utgjør deres DL 50 155 mg/kg (hydrokloridet) og 220 mg/kg (hydrobromidet) ad intravenøs vei på hvite mus (Kaérber og Behrens-metoden). Disse ver- Finally, their DL 50 amounts to 155 mg/kg (the hydrochloride) and 220 mg/kg (the hydrobromide) intravenously in white mice (Kaérber and Behrens method). These ver-
dier er således lavere enn for prokain og kodein. is thus lower than for procaine and codeine.
a-fenyl-a-kloracetater av fS'-alkoksy- α-Phenyl-α-chloroacetates of fS'-Alkoxy-
etyl er i alminnelighet farveløse væsker som selv ved høyt vakuum ikke destillerer over, er oppløselige i alkohol, eter og i andre vanlige organiske oppløsningsmid- ethyl are generally colorless liquids that do not distil over even at high vacuum, are soluble in alcohol, ether and other common organic solvents
ler, men ikke oppløselige i vann. clay, but not soluble in water.
Det følgende eksempel illustrerer opp-finnelsen: The following example illustrates the invention:
Eksempel: Example:
a) a-fenyl-a-kloracetat av |3'-n-butoksy- a) α-phenyl-α-chloroacetate of |3'-n-butoxy-
etyl. ethyl.
I en 250 cm<3->ballong med tre åpnin- In a 250 cm<3->balloon with three openings
ger, utstyrt med et mekanisk røreverk, en bromampulle og en tilbakeløpskjøler, ble det dråpevis og under mekanisk, røring innført en oppløsning av 38 g (0,2 mol/g) a-fenyl-a-kloreddiksyreklorid i 30 cm<3> (3-n-butoksyetanol (tilsetningstid 20 minut- ger, equipped with a mechanical stirrer, a bromine ampoule and a reflux condenser, a solution of 38 g (0.2 mol/g) α-phenyl-α-chloroacetic acid chloride was introduced dropwise and with mechanical stirring into 30 cm<3> ( 3-n-butoxyethanol (addition time 20 minutes-
ter). Blandingen ble oppvarmet under ut- ter). The mixture was heated under
vikling av klorvannstoffsyre. Reaksjonen ble avsluttet ved oppvarming i 2 timer på winding of hydrochloric acid. The reaction was terminated by heating for 2 hours at
et kokende vannbad. a boiling water bath.
Etter avkjøling ble det tilsatt 250 cm<3>After cooling, 250 cm<3> was added
vann, og etter energisk omrøring ble den fraskilte olje underkastet tre suksessive ekstraheringer med 150 cm<3> eter. De sam- water, and after vigorous stirring the separated oil was subjected to three successive extractions with 150 cm<3> of ether. They co-
lete eter-ekstrakter ble tørket på natrium- pale ether extracts were dried over sodium
sulfat og eteren fjernet (de siste spor på sulfate and the ether removed (the last traces on
et vannbad i vakuum). a water bath in a vacuum).
På denne måten ble det oppnådd 54 g (utbytte 100 %) a-fenyl-a-kloracetat av |3'-n-butoksyetyl som i rå tilstand brukes ved den følgende reaksjon. b) a-fenyl-a-piperidinacetat av p'-n-but-oksy-etyl. In this way, 54 g (yield 100%) of α-phenyl-α-chloroacetate of β-3'-n-butoxyethyl was obtained, which is used in the crude state in the following reaction. b) α-phenyl-α-piperidine acetate of p'-n-but-oxy-ethyl.
En blanding av 27 g (0,1 mol/g) a-fenyl-a-kloracetat av p'-n-butoksyetyl og 17 A mixture of 27 g (0.1 mol/g) α-phenyl-α-chloroacetate of p'-n-butoxyethyl and 17
g (0,2 mol/g) piperidin i 150 cm<3> vannfri benzen ble oppvarmet i 8 timer under til-bakeløp. g (0.2 mol/g) of piperidine in 150 cm<3> of anhydrous benzene was heated for 8 hours under reflux.
Reaksjonsblandingen ble avkjølet, pi-peridinhydrokloridet fjernet, og deretter vasket 3 ganger med benzen. Benzenen ble fjernet fra filtratet (blandet med de ben-zenholdige vaskevann) ved avdestillering på vannbad, den oljeaktige rest ble opp-slemmet med 100 cm'<1> vann og derpå underkastet tre suksessive ekstraheringer med 100 cm<3> eter. Eter-ekstraktene ble forenet og vasket suksessivt 2 ganger med 70 cm3 The reaction mixture was cooled, the piperidine hydrochloride removed, and then washed 3 times with benzene. The benzene was removed from the filtrate (mixed with the benzene-containing wash water) by distillation on a water bath, the oily residue was slurried with 100 cm<1> of water and then subjected to three successive extractions with 100 cm<3> of ether. The ether extracts were combined and washed successively 2 times with 70 cc
vann, tørket på natriumsulfat, eteren fjer- water, dried over sodium sulfate, the ether removed
net og resten rektifisert i vakuum. net and the remainder rectified in vacuum.
Det ble oppnådd 22,1 g (utbytte 69,2 22.1 g were obtained (yield 69.2
%) a-fenyl-a-piperidinacetat av p-n-butoksyetyl i form av en f arveløs olje som de- %) a-phenyl-a-piperidine acetate of p-n-butoxyethyl in the form of a colorless oil which de-
stillerer over ved 143—144° ved 0,2 mm. settles over at 143—144° at 0.2 mm.
Stoffet er oppløselig i alkohol og eter, men uoppløselig i vann. The substance is soluble in alcohol and ether, but insoluble in water.
c) Hydrokloridet av basen (b). c) The hydrochloride of the base (b).
Basen ble oppløst i vannfri eter, og i The base was dissolved in anhydrous ether, and i
eteroppløsningen ble det ført inn en strøm av tørr klorvannstoffgass. Etter tørking i vakuum på fosforsyreanhydrid ble det fra- ether solution, a stream of dry hydrogen chloride gas was introduced. After drying in vacuum on phosphoric anhydride, the
skilte hydroklorid utskilt. Det er et amorft, separated hydrochloride excreted. It is an amorphous,
meget hygroskopisk og vannoppløselig stoff. very hygroscopic and water-soluble substance.
d) Hydrobromid av basen (b). d) Hydrobromide of the base (b).
Fremstilt på lignende måte og rekry-stallisert i metylisopropylketon smeltet hydrobromidet ved 99°. Stoffet er meget opp- Prepared in a similar manner and recrystallized from methyl isopropyl ketone, the hydrobromide melted at 99°. The fabric is very high-
løselig i vann og alkohol. soluble in water and alcohol.
På lignende måte kan det fremstilles: In a similar way, it can be produced:
(e) a-fenyl-a-piperidinacetat av p'-met-oksyetyl med et utbytte av 74 %. Dette stoff koker ved 131—132° ved 0,4—0,5 mm, (e) p'-methoxyethyl α-phenyl-α-piperidine acetate in a yield of 74%. This substance boils at 131—132° at 0.4—0.5 mm,
og dets hydroklorid er hygroskopisk; dets hydrobromid smelter ved 108° og er meget oppløselig i vann og alkohol. and its hydrochloride is hygroscopic; its hydrobromide melts at 108° and is very soluble in water and alcohol.
(f) a-fenyl-a-piperidinacetat av (3'-etok- (f) α-phenyl-α-piperidine acetate of (3'-ethoc-
syetyl med et utbytte av 67,8 %. Dette stoff koker ved 140—141° ved 0,5 mm, og dets hydroklorid smelter ved 105° etter re-krystallisering i etylacetat. Hydrobromidet smelter ved 137—138° og er meget opplø- syethyl with a yield of 67.8%. This substance boils at 140-141° at 0.5 mm, and its hydrochloride melts at 105° after recrystallization in ethyl acetate. The hydrobromide melts at 137-138° and is very soluble
selig i vann og i alkohol. soluble in water and in alcohol.
(g) a-fenyl-a-piperidinacetat av p'-n-hek-syloksyetyl med et utbytte av 70,6 %. Dette stoff koker ved 161—162° ved 0,7—0,8 mm, (g) p'-n-hexyloxyethyl α-phenyl-α-piperidine acetate in a yield of 70.6%. This substance boils at 161—162° at 0.7—0.8 mm,
og dets hydroklorid er hygroskopisk. Dets hydrobromid smelter ved 90—91° og er me- and its hydrochloride is hygroscopic. Its hydrobromide melts at 90—91° and is me-
get oppløselig i vann og alkohol. get soluble in water and alcohol.
1. Fremgangsmåte for fremstilling av terapeutisk virksomme basiske estere som har den alminnelige formel 1. Process for the production of therapeutically active basic esters having the general formula
Claims (3)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE00254/70A SE330399B (en) | 1970-01-09 | 1970-01-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO128798B true NO128798B (en) | 1974-01-07 |
Family
ID=20256268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO00068/71A NO128798B (en) | 1970-01-09 | 1971-01-08 |
Country Status (11)
Country | Link |
---|---|
US (1) | US3674960A (en) |
JP (1) | JPS4832859B1 (en) |
BE (1) | BE761264A (en) |
DE (1) | DE2064865B2 (en) |
DK (1) | DK122050B (en) |
FI (1) | FI51645C (en) |
FR (1) | FR2075369A5 (en) |
GB (1) | GB1318683A (en) |
NL (1) | NL7018946A (en) |
NO (1) | NO128798B (en) |
SE (1) | SE330399B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2704671C2 (en) * | 1977-02-04 | 1984-09-13 | Standard Elektrik Lorenz Ag, 7000 Stuttgart | PCB holder |
JPS54182846U (en) * | 1978-05-16 | 1979-12-25 | ||
US11384684B2 (en) | 2019-08-09 | 2022-07-12 | Astron Aerospace Llc | Rotary engine, parts thereof, and methods |
WO2022026777A2 (en) | 2020-07-29 | 2022-02-03 | Astron Aerospace Llc | Rotary engine, parts thereof, and methods |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB786959A (en) * | 1954-09-07 | 1957-11-27 | Telephone Mfg Co Ltd | Improvements in and relating to electromagnetic relays and to apparatus incorporating such relays |
US3242285A (en) * | 1963-03-21 | 1966-03-22 | Guardian Electric Mfg Co | Relay with unitary field piece construction |
GB1217633A (en) * | 1968-03-26 | 1970-12-31 | Omron Tateisi Electronics Co | An electromagnetic relay |
US3493903A (en) * | 1968-08-05 | 1970-02-03 | Westinghouse Air Brake Co | Electromagnetic relay with a suspended armature |
BE754755A (en) * | 1969-08-13 | 1971-01-18 | Western Electric Co | ELECTROMAGNETIC SWITCHING DEVICE |
-
1970
- 1970-01-09 SE SE00254/70A patent/SE330399B/xx unknown
- 1970-12-15 FI FI703379A patent/FI51645C/en active
- 1970-12-17 US US98981A patent/US3674960A/en not_active Expired - Lifetime
- 1970-12-29 NL NL7018946A patent/NL7018946A/xx unknown
- 1970-12-29 JP JP45121889A patent/JPS4832859B1/ja active Pending
- 1970-12-31 DE DE19702064865 patent/DE2064865B2/en not_active Withdrawn
-
1971
- 1971-01-06 BE BE761264A patent/BE761264A/en unknown
- 1971-01-07 DK DK5771AA patent/DK122050B/en unknown
- 1971-01-08 NO NO00068/71A patent/NO128798B/no unknown
- 1971-01-08 GB GB111571A patent/GB1318683A/en not_active Expired
- 1971-01-08 FR FR7100562A patent/FR2075369A5/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK122050B (en) | 1972-01-10 |
DE2064865B2 (en) | 1971-12-23 |
SE330399B (en) | 1970-11-16 |
FR2075369A5 (en) | 1971-10-08 |
US3674960A (en) | 1972-07-04 |
FI51645B (en) | 1976-11-01 |
GB1318683A (en) | 1973-05-31 |
NL7018946A (en) | 1971-07-13 |
FI51645C (en) | 1977-02-10 |
DE2064865A1 (en) | 1971-07-22 |
BE761264A (en) | 1971-06-16 |
JPS4832859B1 (en) | 1973-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4105785A (en) | Anti-depressive 2-methyl-4-[(3'-dimethylamino)propylidine]-9,10-dihydrobenzo [4,5]cyclohepta[1,2b]furan compounds | |
FR2459235A1 (en) | NOVEL SULFONYL-ANILINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
DD207377A5 (en) | PROCESS FOR THE PREPARATION OF NEW THEOPHYLLINE DERIVATIVES | |
US3227716A (en) | Therapeutically-active dibenzocycloheptane derivatives | |
NO128798B (en) | ||
US4242348A (en) | Novel basic substituted-alkylidenamino-oxylalkyl-carboxylic-acid esters | |
US4029808A (en) | Thienyl phenyl O-(aminoalkyl)-ketone oxime and furyl phenyl O-(aminoalkyl)-ketone oxime coronary vasodilators | |
US2561385A (en) | Aranoalkyl-z-tmenyl-cycloalkenyl | |
EP0360784B1 (en) | Thienyloxy-alkylamine derivatives, process for their preparation and therapeutic agents containing these compounds | |
US2918407A (en) | Anti-spasmodics specific for upper gastrointestinal pain and spasm | |
US4018767A (en) | Anti-arrhythmic agents | |
US3487085A (en) | Dihydrothieno benzothiepene | |
US3503952A (en) | Azoxybis(2-phenylacrylic acid,3-tropanyl esters) | |
US2995560A (en) | Acetates of 3-piperidinol | |
US3308129A (en) | 3-tropanyl esters of atropic and thioatropic acids | |
US3466290A (en) | 9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thiophene ethers | |
US2262754A (en) | Antispasmodic agents | |
US3262937A (en) | Benzyl piperidyl ketones | |
US3032556A (en) | Process for the preparation of new | |
US3767802A (en) | Substituted esters of phenyl acetic acids in treating pain and inflammation | |
US3458507A (en) | 3-tropanyl-2-aminophenylacrylate compounds | |
US3519648A (en) | 4,9-dihydrothieno(2,3-b)benzo(e) thiepine derivatives | |
US3565891A (en) | Mannich bases of 3-tropanyl 2-(hydroxyphenyl) acrylates | |
US3609179A (en) | Lower alkyl 9-carboxylates of 9-(tert.-aminobutynyl) fluorenes | |
US3701786A (en) | Dibenzofuranyl-aminoalcohols |